The Business
Research Company’s latest report Ophthalmology Drugs Global Market Report 2020 covers Ophthalmology Drugs market
drivers, Ophthalmology Drugs market trends, Ophthalmology Drugs market
segments, Ophthalmology Drugs market growth rate, Ophthalmology Drugs market
major players, and Ophthalmology Drugs market size. The report provides
in-depth analysis of the impact of COVID-19 on the Ophthalmology Drugs industry,
along with revised market numbers due to the effects of the coronavirus.
View Complete Report:
https://www.thebusinessresearchcompany.com/report/ophthalmology-drugs-market
https://www.thebusinessresearchcompany.com/sample.aspx?id=2142&type=smp
The global ophthalmology drugs market is expected to decline from $24,640.0 million in 2019 to $19,831.3 million in 2020 at a compound annual growth rate (CAGR) of -19.5%. The decline is mainly due to economic slowdown across countries owing to the COVID-19 outbreak and the measures to contain it. The market is then expected to recover and grow at a CAGR of 44.6% from 2021 and reach $33,272.8 million in 2023. The market is expected to grow at a CAGR of 7.2% to nearly $38,223.53 million by 2025, and at a CAGR of 7.0% to $53,698.87 million by 2030.
The report covers
the Ophthalmology Drug market’s segments-
1) By Drug Type:
Antiglaucoma Drugs, Dry Eye Medication, Other Ophthalmology Drugs
2) By Prescription Type: OTC Drugs, Prescription Drugs
3) By Description
Channel: Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, Online
Pharmacies
4) By Drug
Variation: Branded Drugs, Generic Drugs
About
The Business Research Company:
The Business Research Company is a Business Intelligence Company which
excels in company, market and consumer research. It has offices in the UK, the
US and India and a network of trained researchers in 15 countries
globally.
Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
No comments:
Post a Comment